Alps Advisors Inc Johnson & Johnson Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Alps Advisors Inc holds 228,216 shares of JNJ stock, worth $34.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

228,216

Previous 96,027 137.66%

Holding current value

$34.9 Million

Previous $14 Million 163.51%

% of portfolio

0.25%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $19.2 Million - $22.1 Million	132,189 Added 137.66%	228,216 $37 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $107,567 - $112,778	-693 Reduced 0.72%	96,027 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $80,080 - $87,384	550 Added 0.57%	96,720 $15.2 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $10.1 Million - $11.3 Million	-64,990 Reduced 40.33%	96,170 $15 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $627,124 - $674,904	-4,063 Reduced 2.46%	161,160 $26.7 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $3.22 Million - $3.84 Million	-21,309 Reduced 11.42%	165,223 $25.6 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.78 Million - $2 Million	-11,139 Reduced 5.64%	186,532 $33 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $9.75 Million - $10.9 Million	-60,450 Reduced 23.42%	197,671 $32.3 Million
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $42.6 Million - $47.1 Million	253,237 Added 5185.03%	258,121 $45.8 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $180,121 - $204,553	-1,139 Reduced 18.91%	4,884 $866,000
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $27.3 Million - $30.3 Million	-175,282 Reduced 96.68%	6,023 $1.03 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $197,999 - $220,030	-1,226 Reduced 0.67%	181,305 $29.3 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $7,655 - $8,211	-48 Reduced 0.03%	182,531 $30.1 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $1,836 - $2,045	-12 Reduced 0.01%	182,579 $30 Million
Q4 2020 Feb 03, 2021	SELL	$137.11 - $157.38 $30,986 - $35,567	-226 Reduced 0.12%	182,591 $28.7 Million
Q3 2020 Nov 04, 2020	SELL	$140.38 - $153.83 $57,696 - $63,224	-411 Reduced 0.22%	182,817 $27.2 Million
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $3.78 Million - $4.56 Million	-29,339 Reduced 13.8%	183,228 $25.8 Million
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $136,368 - $188,945	-1,227 Reduced 0.57%	212,567 $27.9 Million
Q4 2019 Feb 07, 2020	SELL	$127.5 - $146.44 $231,030 - $265,349	-1,812 Reduced 0.84%	213,794 $31.2 Million
Q3 2019 Nov 04, 2019	SELL	$126.95 - $142.14 $6.99 Million - $7.83 Million	-55,099 Reduced 20.35%	215,606 $27.9 Million
Q2 2019 Aug 07, 2019	SELL	$131.15 - $144.24 $316,202 - $347,762	-2,411 Reduced 0.88%	270,705 $37.7 Million
Q1 2019 May 01, 2019	BUY	$125.72 - $139.79 $234,090 - $260,288	1,862 Added 0.69%	273,116 $38.2 Million
Q4 2018 Feb 04, 2019	SELL	$122.84 - $147.84 $89,550 - $107,775	-729 Reduced 0.27%	271,254 $35 Million
Q3 2018 Oct 25, 2018	BUY	$121.58 - $142.88 $813,491 - $956,010	6,691 Added 2.52%	271,983 $37.6 Million
Q2 2018 Aug 02, 2018	BUY	$119.4 - $131.76 $664,461 - $733,244	5,565 Added 2.14%	265,292 $32.2 Million
Q2 2018 Jul 25, 2018	BUY	$119.4 - $131.76 $29.2 Million - $32.2 Million	244,667 Added 1624.61%	259,727 $36.3 Million
Q1 2018 May 01, 2018	BUY	$125.1 - $148.14 $667,158 - $790,030	5,333 Added 54.83%	15,060 $1.93 Million
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $44.7 Million - $48.9 Million	-340,683 Reduced 97.22%	9,727 $1.36 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $45.4 Million - $47.4 Million	350,410	350,410 $45.6 Million

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Johnson & Johnson Transaction History